SCHEDULE I - CONDENSED FINANCIAL INFORMATION OF THE REGISTRANT [Schedule] Condensed Statements of Cash Flows (Details) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended			17 Months Ended
	Dec. 31, 2016	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2016
Cash flows from operating activities:
Net income (loss)	$ (292)	$ (1,873)	$ (3,138)	$ (3,487)	$ (2,626)	$ (2,084)	$ 13,877	$ (6,838)	$ (8,790)	$ 2,329	$ (13,194)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization									3,090	3,845	5,835
Stock-based compensation									1,449	4,231	1,325
Other, net									211	194	354
Changes in operating assets and liabilities, net of effect of dispositions:
(Increase) decrease in prepaid and other assets									1,053	2,763	(1,731)
Increase (decrease) in accounts payable, accrued expenses and other liabilities									(3,317)	(7,902)	4,213
Increase (decrease) in accrued business reorganization									(2,552)	(679)	2,684
Net cash provided by (used in) operating activities									(9,420)	(17,351)	(17,840)
Cash flows from investing activities:
Capital expenditures									(2,766)	(3,061)	(5,346)
Net cash provided by (used in) investing activities									(2,724)	21,648	16,731
Cash flows from financing activities:
Borrowings under credit agreements									118,583	147,429	133,030
Payments of Ordinary Dividends, Common Stock									(3,401)	0	0
Payments for Repurchase of Common Stock									(5,127)	(1,386)	0	$ (6,513)
Purchase of restricted stock from employees									(65)	(244)	(138)
Net cash provided by (used in) financing activities									(2,930)	644	(1,256)
Net increase (decrease) in cash and cash equivalents									(16,341)	3,674	(3,389)
Cash and cash equivalents, beginning of the period				37,663				33,989	37,663	33,989	37,378
Cash and cash equivalents, end of the period	21,322				37,663				21,322	37,663	33,989	21,322
Parent Company
Cash flows from operating activities:
Net income (loss)									(8,790)	2,329	(13,194)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Dividends received from subsidiaries									1,593	7,468	0
Non-cash (income) losses from subsidiaries, net of taxes									2,363	(11,466)	2,995
Depreciation and amortization									405	488	541
Stock-based compensation									390	637	405
Other, net									0	0	248
Changes in operating assets and liabilities, net of effect of dispositions:
(Increase) decrease in prepaid and other assets									(447)	1,921	(744)
(Increase) decrease in due from subsidiaries									4,959	14,503	11,910
Increase (decrease) in accounts payable, accrued expenses and other liabilities									(1,251)	(1,269)	837
Increase (decrease) in accrued business reorganization									(825)	(120)	793
Net cash provided by (used in) operating activities									(1,603)	14,491	3,791
Cash flows from investing activities:
Capital expenditures									0	(897)	0
Advances to and investments in subsidiaries, net									(415)	(5,945)	(4,126)
Net cash provided by (used in) investing activities									(415)	(6,842)	(4,126)
Cash flows from financing activities:
Borrowings under credit agreements									0	0	22,081
Repayments under credit facility									0	0	(22,081)
Payments of Ordinary Dividends, Common Stock									(3,401)	0	0
Payments for Repurchase of Common Stock									(5,127)	(1,386)	0
Purchase of restricted stock from employees									(65)	(244)	(129)
Net cash provided by (used in) financing activities									(8,593)	(1,630)	(129)
Net increase (decrease) in cash and cash equivalents									(10,611)	6,019	(464)
Cash and cash equivalents, beginning of the period				$ 13,025				$ 7,006	13,025	7,006	7,470
Cash and cash equivalents, end of the period	$ 2,414				$ 13,025				$ 2,414	$ 13,025	$ 7,006	$ 2,414